A Myeloma Screen Blood Test is primarily used to diagnose and monitor multiple myeloma, a type of blood cancer that affects plasma cells in the bone marrow. The test typically involves a combination of blood tests designed to assess the presence of abnormal proteins, organ function, and the overall blood cell count.
Key Components of a Myeloma Screen:
- FBC
- ESR
- Biochemistry Profile
- Protein Electrophoresis
- Immunoglobulins (IgA, lgG, IgM)
- Bence-Jones Protein
Why It’s Important:
- Diagnosis: Helps confirm the presence of multiple myeloma or other plasma cell disorders.
- Monitoring Disease Progression: Regular screening can help assess how well the disease is responding to treatment and identify any progression.
- Guiding Treatment Decisions: Results can influence treatment options, including chemotherapy, targeted therapies, and stem cell transplantation.
Preparation for the Test:
- Typically, no special preparation is required, but it’s always best to follow your healthcare provider’s instructions regarding fasting or medication adjustments.
Interpretation of Results:
- Results must be interpreted in the context of clinical symptoms, imaging studies, and other diagnostic information. Abnormal results may prompt further testing or referrals to specialists.
Results – 5 days from Laboratory receiving sample
